U.S. Software Stock News

Praxis Precision Medicines (NasdaqGS:PRAX) reported that the FDA accepted New Drug Applications for ulixacaltamide and relutrigine. The company is preparing for potential U.S. launches following these NDA acceptances. Praxis also highlighted clinical progress for elsunersen, adding to momentum across its late-stage pipeline. For readers tracking central nervous system drug developers, Praxis sits at an important point in its evolution, with ulixacaltamide and relutrigine moving into formal...

If you are wondering whether Gulfport Energy, at a last close of US$178.80, is attractively priced or if the easy gains are behind it, this article breaks down what the current share price might be implying about the stock's value. The stock has seen a 7.1% decline over the last week, a 13.9% decline over the last month, and a 13.3% decline year to date, set against a 94.6% return over the last 3 years and a 5.0% decline over the last year. Recent coverage has focused on Gulfport Energy's...

EIR Healthcare recently announced a partnership with MillerKnoll to integrate casework, furniture, and interior solutions directly into factory-built healthcare modules, aiming to deliver fully furnished, quality-checked clinics from day one. This move embeds MillerKnoll into an emerging offsite healthcare construction model that targets faster, more reliable delivery of behavioral health facilities funded by large public programs. We’ll now examine how embedding MillerKnoll’s solutions into...

For investors considering whether Cardinal Health's share price still offers value after a strong multi year run, this article explains what the current market price could be implying about the stock. The stock last closed at US$185.28, with returns of 27.2% over 1 year, 129.5% over 3 years and 270.6% over 5 years. This comes despite 7 day, 30 day and year to date returns of 3.9%, 12.9% and 9.9% declines respectively. Recent coverage around Cardinal Health has focused on its role as a major...

Why Element Solutions (ESI) is in focus after its latest earnings Element Solutions (ESI) recently reported first quarter results, with sales of US$840 million versus US$593.7 million a year earlier, while net income was US$55.9 million compared with US$98 million. See our latest analysis for Element Solutions. Even with a 4.45% 1-day share price decline to US$42.27 after earnings and a modest 7-day pullback, Element Solutions still sits on a 22.17% 1-month share price return and a 100.61%...

Aura Minerals reported record Q1 profits and record EBITDA, marking a turnaround from a loss in the prior year. The Board declared a dividend that exceeds the company's own minimum payout policy, indicating higher shareholder returns in the period. The stock, NasdaqGS:AUGO, last closed at $81.07, with very large 1 year and 3 year returns and a 62.1% gain year to date. For investors who have been tracking NasdaqGS:AUGO, this update focuses on fresh company news rather than past valuation...

Warner Music Group (WMG) opened Q1 2026 with revenue of US$1.8 billion, basic EPS of US$0.33 and net income of US$174 million, setting the tone for how investors will read the latest update against a year of compressed margins. The company has reported quarterly revenue of US$1.63 billion in Q4 2024, US$1.87 billion in Q4 2025 and US$1.84 billion in Q1 2026. Over the same period, basic EPS has ranged from US$0.08 in Q4 2024 to US$0.45 in Q1 2025 and US$0.33 in the latest quarter, leaving...

Why Suncrete (RMIX) is on investors’ radar Suncrete (RMIX) has drawn attention after a strong share price move over the past month, with the stock returning 46.5% across that period and 34.6% over the past 3 months. See our latest analysis for Suncrete. That swing in momentum, with a 46.5% 1 month share price return and 35.1% year to date share price return, sits alongside a 39.4% 1 year total shareholder return at a latest close of $15.40. If Suncrete’s recent move has you thinking about...

Sana Biotechnology (SANA) is back in focus as CEO Steve Harr prepares to deliver a business overview and company update at the BofA Securities 2026 Healthcare Conference on May 12. See our latest analysis for Sana Biotechnology. At a share price of $3.50, Sana’s 7 day share price return of 6.38% and 30 day share price return of 11.11% contrast with a year to date share price decline of 16.47%. The 1 year total shareholder return of 93.37% sits against weaker 3 and 5 year total shareholder...

If you are wondering whether Asana’s current share price reflects its true worth, this breakdown will help you weigh what the market is pricing in against what the fundamentals suggest. Asana’s stock last closed at US$7.05, with a 7 day return of 11.6% and a 30 day return of 13.7%. However, the year to date return of negative 45.6% and 1 year return of negative 59.1% highlight that many holders have faced a tough ride. Those recent moves sit against a backdrop of ongoing coverage around...

Raymond James Financial (NYSE:RJF) has rolled out its Client 360 platform and an artificial intelligence learning academy for financial advisors. The company is committing a reported US$1.1b to technology, including AI powered tools aimed at improving advisor productivity and client service. Raymond James has closed its acquisition of Clark Capital Management Group and introduced proprietary active ETFs to expand its asset management menu. For investors following wealth management and...

Zoetis (ZTS) has opened 2026 with Q1 revenue of US$2.3b and basic EPS of US$1.42, setting the tone for how investors read the latest earnings update. The company has seen quarterly revenue move from US$2.2b in Q1 2025 to US$2.3b in Q1 2026, while basic EPS shifted from US$1.41 to US$1.42 over the same period, giving you a clear view of how the top and bottom lines are tracking year on year. Against that backdrop, the focus now is on how sustainably Zoetis is converting this revenue into...

Artificial intelligence in healthcare sits at the crossroads of powerful data, rising care costs, and a world focused on inflation, energy shocks, and supply chain shifts. While oil, rates, and trade headlines pull markets in different directions, AI tools that can improve accuracy, access, and affordability in medicine are drawing close attention. The Transformative AI Healthcare Stocks screener looks for companies using AI to sharpen diagnostics, personalise treatment, streamline clinical...

If you are wondering whether Veradermics’ current share price lines up with its underlying value, this article breaks down what the numbers may indicate about the stock. Veradermics recently closed at US$107.85, with returns of 8.9% over 7 days, 90.2% over 30 days and 185.7% year to date. This puts the current price action firmly in focus for valuation-minded investors. Recent coverage around Veradermics has centered on its position within the Pharmaceuticals industry and how investors are...

If you are wondering whether Darling Ingredients at around US$62 is offering fair value or a potential discount right now, this article breaks down what the current price may be implying about the stock. The share price is at US$62.27, with a 3.1% decline over the last 7 days and a 2.0% decline over 30 days, set against a 65.4% gain year to date and an 84.0% return over the past year. This mix of recent pullbacks and longer term gains can change how you think about both upside and...

Omega Healthcare Investors (NYSE:OHI) is selling CommuniCare’s skilled nursing assets to lower tenant concentration risk. The move is part of a broader portfolio cleanup that also considers financial pressures at Maplewood and Genesis. The company aims to support dividend stability and overall portfolio health as operator stress continues across the sector. For investors watching NYSE:OHI at a share price of $46.13, this portfolio cleanup follows a very large 3-year return and a 94.0%...

In April 2026, Everspin Technologies announced a US$40,000,000, 30‑month subcontract with Amentum Services under a U.S. Navy microelectronics RDT&E program, alongside first‑quarter 2026 results showing higher revenue and a smaller net loss than a year earlier. The deal ties Everspin’s Toggle MRAM process technology directly into U.S. defense supply chains, reinforcing its role as an on‑shore memory partner for critical systems. Next, we’ll examine how this US$40,000,000 defense-focused...

Wondering if ASML Holding at around US$1,516.60 is priced for perfection or still offers value? This article breaks down what the current share price really implies for you. The stock has returned 5.4% over the last week, 16.1% over the last month, 30.3% year to date and 115.6% over the past year, which naturally raises questions about where value and risk now sit. Recent coverage around ASML has emphasized its central role in semiconductor equipment and its importance to chip manufacturing...

Wondering whether Citizens Financial Group stock still offers value after its strong run, or if most of the easy gains are already behind it? This article walks through the key signals you can use to make that call. The stock last closed at US$64.22, with returns of 4.3% over 30 days, 8.1% year to date and 70.0% over 1 year, which can change how the market views both its growth potential and its risk profile. Recent coverage has focused on Citizens Financial Group's positioning as a major US...

Pomerantz LLP has opened an investigation into CarMax (NYSE:KMX) for potential securities fraud or other unlawful business practices. The inquiry follows CarMax's April 14, 2026 decision to lower used car prices and accept higher credit risk in response to an auto affordability crisis. The combination of a pricing shift and looser credit standards raises questions about risk management, disclosure, and long term business impacts. CarMax runs one of the largest used car retail operations in...

If you are wondering whether BioMarin Pharmaceutical's current share price reflects its true value, a useful starting point is understanding how the market has treated the stock recently. BioMarin's share price closed at US$54.12, with returns of 0.4% over 7 days, a 3.7% decline over 30 days, a 9.0% decline year to date, and a 9.5% decline over the last year, alongside longer term 43.3% and 28.3% declines over 3 and 5 years. These returns suggest many investors are likely reassessing whether...

This article examines whether Coty, trading at around US$2.50, may represent a bargain or a value trap by exploring what the current price could be implying about the stock. Coty's share price has moved by 1.6% over the last week and 18.5% over the last month. However, the stock is still showing a year to date return of a 19.6% decline and a 1 year return of a 48.1% decline. Recent news around Coty has focused on its positioning as a global beauty company, including ongoing brand activity...

Palladyne AI Corp. recently reported past first-quarter 2026 results with revenue rising to US$3.54 million from US$1.71 million a year earlier, while swinging to a net loss of US$12.61 million and reaffirming full-year 2026 revenue guidance of US$24 million to US$27 million. The company also disclosed a roughly US$17 million backlog and new defense and space contracts, underlining growing demand for its embodied AI and autonomous systems offerings. Next, we’ll examine how reaffirmed...

Century Aluminum (CENX) put up steady top line numbers in FY 2025, with fourth quarter revenue of US$633.7 million and basic EPS of US$0.02, capping a trailing twelve month run of US$2.5 billion in revenue and EPS of US$0.42. Over the past reported periods, quarterly revenue has moved in a tight band between US$628.1 million and US$633.9 million, while basic EPS has ranged from a quarterly loss of US$0.05 to a high of US$0.30. This sets up a story where investors are weighing solid revenue...